tiprankstipranks
Roivant Sciences (DE:87S)
FRANKFURT:87S
Germany Market
87S
Roivant Sciences
RESEARCH TOOLSreports

Roivant Sciences (87S) Ratios

2 Followers

Roivant Sciences Ratios

DE:87S's free cash flow for Q1 2026 was $0.80. For the 2026 fiscal year, DE:87S's free cash flow was decreased by $ and operating cash flow was $-204.27. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 16.72 18.37 33.47 25.24 6.60
Quick Ratio
 16.72 18.37 33.47 25.10 6.59
Cash Ratio
 4.40 5.06 18.17 24.50 6.15
Solvency Ratio
 -0.67 -0.68 -0.63 5.65 -1.27
Operating Cash Flow Ratio
 -2.85 -2.67 -5.62 -2.87 -3.10
Short-Term Operating Cash Flow Coverage
 0.00 -67.31 -85.29 -63.77 -20.71
Net Current Asset Value
$ 4.36B$ 4.73B$ 4.75B$ 5.96B$ 1.02B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.02 0.07 0.20
Debt-to-Equity Ratio
 0.03 0.02 0.02 0.08 0.42
Debt-to-Capital Ratio
 0.02 0.02 0.02 0.08 0.29
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.07 0.24
Financial Leverage Ratio
 1.25 1.27 1.16 1.21 2.06
Debt Service Coverage Ratio
 0.00 -35.40 -72.72 -17.62 -17.23
Interest Coverage Ratio
 0.00 0.00 0.00 129.31 -42.02
Debt to Market Cap
 0.00 <0.01 <0.01 0.05 0.08
Interest Debt Per Share
 0.15 0.15 0.14 0.68 0.71
Net Debt to EBITDA
 4.06 5.04 3.92 7.52 1.01
Profitability Margins
Gross Profit Margin
81.21%84.44%96.86%95.11%78.58%
EBIT Margin
-3848.65%-3203.12%-2346.02%-2521.71%-1953.11%
EBITDA Margin
-3735.25%-3162.59%-2297.59%-2454.35%-1922.34%
Operating Profit Margin
-18140.92%-15560.57%-3833.27%13746.93%-1917.95%
Pretax Profit Margin
-3848.65%-3203.12%-2346.02%13963.43%-1998.75%
Net Profit Margin
-3534.88%-3629.19%-591.96%13294.18%-1646.59%
Continuous Operations Profit Margin
-5504.46%-4817.28%-2511.84%13897.70%-2007.22%
Net Income Per EBT
91.85%113.30%25.23%95.21%82.38%
EBT Per EBIT
21.22%20.58%61.20%101.57%104.21%
Return on Assets (ROA)
-5.02%-5.23%-3.16%60.21%-42.23%
Return on Equity (ROE)
-6.12%-6.62%-3.67%72.86%-87.15%
Return on Capital Employed (ROCE)
-27.20%-23.60%-21.06%64.65%-55.51%
Return on Invested Capital (ROIC)
-27.14%-23.55%-21.02%64.15%-54.17%
Return on Tangible Assets
-5.02%-5.23%-3.16%61.39%-44.95%
Earnings Yield
-1.06%-1.56%-2.35%53.24%-19.18%
Efficiency Ratios
Receivables Turnover
 <0.01 0.01 0.00 0.40 1.63
Payables Turnover
 0.06 0.07 0.04 0.03 0.35
Inventory Turnover
 0.00 0.00 0.00 0.05 4.75
Fixed Asset Turnover
 0.08 0.09 0.29 0.50 0.66
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 0.03
Working Capital Turnover Ratio
 <0.01 <0.01 <0.01 <0.01 0.04
Cash Conversion Cycle
 31.97K 29.79K -9.49K -3.18K -750.81
Days of Sales Outstanding
 38.44K 34.90K 0.00 924.00 224.22
Days of Inventory Outstanding
 0.00 0.00 0.00 8.05K 76.76
Days of Payables Outstanding
 6.47K 5.11K 9.49K 12.15K 1.05K
Operating Cycle
 38.44K 34.90K 0.00 8.97K 300.98
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.12 -1.08 -1.16 -0.98 -1.18
Free Cash Flow Per Share
 -1.13 -1.09 -1.16 -0.98 -1.20
CapEx Per Share
 <0.01 0.01 <0.01 <0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.01 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -176.22 -91.41 -182.53 -103.67 -66.46
Capital Expenditure Coverage Ratio
 -176.22 -91.41 -182.53 -553.74 -66.46
Operating Cash Flow Coverage Ratio
 -7.55 -6.98 -8.38 -1.53 -1.75
Operating Cash Flow to Sales Ratio
 -107.46 -90.84 -28.89 -23.39 -13.76
Free Cash Flow Yield
-3.23%-3.95%-11.53%-9.38%-16.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -91.92 -64.42 -42.04 1.88 -5.21
Price-to-Sales (P/S) Ratio
 3.35K 2.33K 251.93 249.73 85.84
Price-to-Book (P/B) Ratio
 5.95 4.25 1.56 1.37 4.54
Price-to-Free Cash Flow (P/FCF) Ratio
 -31.00 -25.34 -8.67 -10.66 -6.14
Price-to-Operating Cash Flow Ratio
 -31.11 -25.61 -8.72 -10.68 -6.24
Price-to-Earnings Growth (PEG) Ratio
 0.77 -0.81 0.40 >-0.01 -0.41
Price-to-Fair Value
 5.95 4.25 1.56 1.37 4.54
Enterprise Value Multiple
 -85.63 -68.54 -7.05 -2.66 -3.45
Enterprise Value
 24.09B 17.90B 4.70B 2.13B 4.06B
EV to EBITDA
 -85.63 -68.54 -7.05 -2.66 -3.45
EV to Sales
 3.20K 2.17K 161.91 65.21 66.33
EV to Free Cash Flow
 -29.60 -23.60 -5.57 -2.78 -4.75
EV to Operating Cash Flow
 -29.77 -23.86 -5.60 -2.79 -4.82
Tangible Book Value Per Share
 6.83 7.63 7.15 8.06 2.05
Shareholders’ Equity Per Share
 5.87 6.52 6.46 7.62 1.62
Tax and Other Ratios
Effective Tax Rate
 -0.43 -0.50 -0.07 <0.01 >-0.01
Revenue Per Share
 0.01 0.01 0.04 0.04 0.09
Net Income Per Share
 -0.37 -0.43 -0.24 5.55 -1.42
Tax Burden
 0.92 1.13 0.25 0.95 0.82
Interest Burden
 1.00 1.00 1.00 -5.54 1.02
Research & Development to Revenue
 97.04 82.54 18.95 13.45 8.57
SG&A to Revenue
 85.23 73.91 20.36 12.72 9.80
Stock-Based Compensation to Revenue
 35.25 41.91 9.95 6.10 3.55
Income Quality
 2.24 1.89 2.35 -0.18 0.76
Currency in USD